Tissue Genesis Introduces State-of-the-Art Icellator(R) X

General Press Releases Wednesday December 12, 2018 11:20
HOUSTON--17 Dec--PRNewswire/InfoQuest
  • The enhanced enzyme-derived stem cell isolation system offers a greater overall impact and efficiency in the field of regenerative medicine
Tissue Genesis LLC announced today the release of the Icellator(R) X, the newest and most advanced system for isolating stem cells in adipose tissue.
The Icellator(R) X expands on the capabilities of the original Icellator(R), representing a major advancement in the real-world application of stem therapies for patients.

The new-to-market Icellator(R) X offers greater stem cell yields, improved ease of use, and a user interface available in multiple languages. It is immediately the most efficient system available on the market. The 2019 Icellator(R) X lets medical professionals and scientists rapidly recover millions of a patient's own adult stem cells for therapeutic treatments and research applications.

The Icellator(R) X is on exhibit at the 16th-annual iFats (International Federation for Adipose Therapeutics and Science) Conference at the Cosmopolitan Las Vegas from Dec. 13-15. (Booth #302) For more information, visit https://www.ifats.org.

Capabilities of the Icellator(R) X include:
  • Input Lipoaspirate Volume up to 100 mL
  • Consistent isolation of high stromal vascular fraction (SVF) cell yields
  • Typical 50 million SVF cell recovery per 100 mL of adipose tissue
  • Cell suspension safe for IV delivery
  • Approximate 1 hour run time
  • Touchscreen user interface available in multiple languages
  • Sterile, single-use disposable cartridge treatment kit
  • IEC 60601 compliant
  • UL listed to IEC 60601 compliant

"The Icellator(R) X continues the tradition of Tissue Genesis Icellators being the most efficient point of care system available," said Tissue Genesis Chief Executive Officer and Chief Medical Officer Dr. Marc Penn, M.D., Ph.D., FACC. "With this new machine, we are able to efficiently obtain far greater stem cell yields, which represents a major step forward for researchers, clinicians, and patients."

"We are excited to collaborate with Tissue Genesis to represent the Icellator X in Japan," said Human Life CORD President Masamitsu Harata. "The literature demonstrates that enzyme derived SVF is the most potent preparation for adipose derived stem cells. We believe the efficiency of Icellator X makes it the premier system in Asia."

The Tissue Genesis Icellator(R) X is designed for maximum simplicity in use by clinical staff: an efficient, enclosed, and automated process. Using a proprietary and sterile single-use Cartridge Kit, the Icellator(R) X isolates a consistent yield of stromal vascular fraction (SVF from a small sample of adipose tissue in about one hour, using a patented purification process.

"The Icellator X is a significant upgrade to our original Icellator system, incorporating feedback from users who can now process more fat. The new Icellator optimizes cell yields using the latest hardware and software technologies," said Tissue Genesis Director of Product Management Dr. Rolf Wolters, Ph.D.

The original Icellator(R) is already used across the globe to enhance the outcomes of patients seeking to treat chronic conditions or to improve their wellness and healthy living. The new Icellator(R)(R) X moves Tissue Genesis forward as the leader in the production of stromal vascular fraction (SVF) from a patient's own adipose fat-derived stem cells.


Tissue Genesis, LLC, (TG) offers best-in-class, clinical grade cell therapy solutions. Its state-of-the-art Icellator(R) X is a high-performance, point-of-care device that efficiently extracts adult stem cells from a small sample of autologous adipose tissue in a fully enclosed and automated process. Manufactured under cGMP to the highest ISO 13485 and FDA standards, the Icellator(R) requires no human intervention and provides yields of stromal vascular fraction that is sufficiently pure to allow for intravenous infusion in an hour or less. Founded in 2001, TG is part of the Okyanos Global Health, Inc. portfolio of companies dedicated to accelerating life sciences through novel therapeutics and commercial innovations. Tissue Genesis' original Icellator(R) is approved for use by medical regulatory authorities in South Korea, the Ukraine and the Bahamas, with ongoing FDA-cleared trials for multiple indications of chronic disease.

To learn more about Tissue Genesis and its products visit: http://www.tissuegenesis.com/

Human Life CORD Inc.'s underlying corporate mission is "Cords of life, leading the future." Founded in early 2017, Human Life CORD is a specialty therapeutics company focused on regenerative medicine and regenerative related medical devices addressing underserved medical needs. Led by President Masamitsu Harata. Human Life Cord distributes leading edge regenerative medical products and therapeutics in Japan and Asian markets, providing expertise and support to research institutions, clinics and hospitals.

Media Contact: Erik Borg
Ph: (212) 584-7829
Email: erik@theleadpr.com
Media Contact at Human Life CORD:
Rika Fukazawa
Photo - https://mma.prnewswire.com/media/796369/Human_Life_CORD.jpg
Logo - https://mma.prnewswire.com/media/590557/Tissue_Genesis_LLC_Logo.jpg

Latest Press Release

Taisho-Tei rolls out a parade of great value ramen and donburi

If you happen to be at IMPACT Muang Thong Thani, don't miss a chance to try delicious ramen with four options of flavorful soup base and other scrumptious Japanese dishes at Taisho-Tei . The restaurant has recently rolled out a special menu featuring...


Calling all mango lovers! Mango Afternoon Tea Treat + SPA Moments is back by popular demand! Make the most of high season for the sweetest + smoothest mangoes to elevate your afternoon tea experience at Latitude 13, and rejuvenate mind, body and soul at...

The 43rd CIFF concludes after hosting some 300,000 professional visitors

The 43rd China International Furniture Fair (Guangzhou) (CIFF), viewed by industry watchers as having been a great success, concluded on March 31. The fair was held in two phases, from March 18 to 21 and from March 28 to 31, bringing together 4,344...

Photo Release: Anantara Donates Over THB 1.8 Million to the Princess Sirindhorn Craniofacial Center at Chulalongkorn Hospital

Anantara Donates Over THB 1.8 Million to the Princess Sirindhorn Craniofacial Center at Chulalongkorn Hospital Anantara Hotels and Resorts recently donated over THB 1.8 million to the Princess Sirindhorn Craniofacial Center at King Chulalongkorn Memorial...

The 43rd CIFF features wider diversification of exhibits and upgraded services

The 43rd China International Furniture Fair (Guangzhou) (CIFF), which was held in two segments, took place in Pazhou, a subdistrict of Haizhu in southeastern Guangzhou, from March 18 to 21 and from March 28 to 31. At the 760,000-square meter event, over...

Related Topics